Meiogenix
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- $7.2M
Investors
- 5
About Meiogenix
Founded in 2010 and headquartered in Paris, France, Meiogenix SAS specializes in agricultural biotechnology, focusing on enhancing crop genetic diversity.Meiogenix specializes in innovative agricultural biotechnology, focusing on Chromosome Editing to enhance crop genetic diversity. Their core offerings aim to unlock unexplored genetic traits in crops, thereby creating novel natural varieties tailored to meet the challenges of climate change, sustainability, and food security. These products are designed for farmers seeking solutions to improve crop resilience and yield without relying on traditional genetic modification techniques.In the most recent year, Meiogenix reported revenue of EUR 1,867,600 and an EBITDA of EUR 853,639. The company generates revenue through strategic partnerships and collaborations with agricultural producers and research institutions, licensing its Chromosome Editing technologies on a B2B basis. The company is also targeting expansion into additional markets in Asia and North America by 2024, aiming to address the increasing demand for sustainable agricultural solutions. This growth strategy is designed to foster long-term partnerships that align with their mission to enhance agricultural sustainability and biodiversity.
Who invested in Meiogenix
5 investors across 1 round
See all investors in Meiogenix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 2, 2021
Amount
$7.2M
Investors
Questions about Meiogenix
Who invested in Meiogenix?
Meiogenix has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Meiogenix raised?
Meiogenix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Meiogenix last raise money?
Meiogenix's most recent round on record is a Series A, in Aug 2021.
What does Meiogenix do?
Founded in 2010 and headquartered in Paris, France, Meiogenix SAS specializes in agricultural biotechnology, focusing on enhancing crop genetic diversity.
Where is Meiogenix headquartered?
Meiogenix is headquartered in Paris, France.
Which VCs invest in companies like Meiogenix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Meiogenix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Meiogenix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.